Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance.

Kolli M, Stawiski E, Chappey C, Schiffer CA.

J Virol. 2009 Nov;83(21):11027-42. doi: 10.1128/JVI.00628-09. Epub 2009 Aug 12.

2.

A new human immunodeficiency virus derived from gorillas.

Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, Lemée V, Damond F, Robertson DL, Simon F.

Nat Med. 2009 Aug;15(8):871-2. doi: 10.1038/nm.2016. Epub 2009 Aug 2.

PMID:
19648927
3.

Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir.

Masquelier B, Assoumou KL, Descamps D, Bocket L, Cottalorda J, Ruffault A, Marcelin AG, Morand-Joubert L, Tamalet C, Charpentier C, Peytavin G, Antoun Z, Brun-Vézinet F, Costagliola D; ANRS Resistance Study Group.

J Antimicrob Chemother. 2008 Jun;61(6):1362-8. doi: 10.1093/jac/dkn127. Epub 2008 Apr 4.

PMID:
18390885
4.

HIV diversity, recombination and disease progression: how does fitness "fit" into the puzzle?

Tebit DM, Nankya I, Arts EJ, Gao Y.

AIDS Rev. 2007 Apr-Jun;9(2):75-87. Review.

PMID:
17694675
5.

Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors.

Poveda E, de Mendoza C, Martin-Carbonero L, Corral A, Briz V, González-Lahoz J, Soriano V.

J Antimicrob Chemother. 2007 Oct;60(4):885-8. Epub 2007 Jul 23.

PMID:
17646201
6.

Mechanism of drug resistance due to N88S in CRF01_AE HIV-1 protease, analyzed by molecular dynamics simulations.

Ode H, Matsuyama S, Hata M, Hoshino T, Kakizawa J, Sugiura W.

J Med Chem. 2007 Apr 19;50(8):1768-77. Epub 2007 Mar 17.

PMID:
17367119
7.
8.

Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.

Hemelaar J, Gouws E, Ghys PD, Osmanov S.

AIDS. 2006 Oct 24;20(16):W13-23.

PMID:
17053344
9.

Resistant mechanism against nelfinavir of human immunodeficiency virus type 1 proteases.

Ode H, Ota M, Neya S, Hata M, Sugiura W, Hoshino T.

J Phys Chem B. 2005 Jan 13;109(1):565-74.

PMID:
16851048
10.

Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir.

Clemente JC, Coman RM, Thiaville MM, Janka LK, Jeung JA, Nukoolkarn S, Govindasamy L, Agbandje-McKenna M, McKenna R, Leelamanit W, Goodenow MM, Dunn BM.

Biochemistry. 2006 May 2;45(17):5468-77.

11.

Optimal description of a protein structure in terms of multiple groups undergoing TLS motion.

Painter J, Merritt EA.

Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):439-50. Epub 2006 Mar 18.

PMID:
16552146
12.
13.

Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate.

Kolli M, Lastere S, Schiffer CA.

Virology. 2006 Apr 10;347(2):405-9. Epub 2006 Jan 20.

14.

HIV-1 subtypes: epidemiology and significance for HIV management.

Geretti AM.

Curr Opin Infect Dis. 2006 Feb;19(1):1-7. Review.

PMID:
16374210
15.

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.

Kantor R, Katzenstein DA, Efron B, Carvalho AP, Wynhoven B, Cane P, Clarke J, Sirivichayakul S, Soares MA, Snoeck J, Pillay C, Rudich H, Rodrigues R, Holguin A, Ariyoshi K, Bouzas MB, Cahn P, Sugiura W, Soriano V, Brigido LF, Grossman Z, Morris L, Vandamme AM, Tanuri A, Phanuphak P, Weber JN, Pillay D, Harrigan PR, Camacho R, Schapiro JM, Shafer RW.

PLoS Med. 2005 Apr;2(4):e112. Epub 2005 Apr 26.

16.

Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.

Surleraux DL, Tahri A, Verschueren WG, Pille GM, de Kock HA, Jonckers TH, Peeters A, De Meyer S, Azijn H, Pauwels R, de Bethune MP, King NM, Prabu-Jeyabalan M, Schiffer CA, Wigerinck PB.

J Med Chem. 2005 Mar 24;48(6):1813-22.

PMID:
15771427
17.

Coot: model-building tools for molecular graphics.

Emsley P, Cowtan K.

Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32. Epub 2004 Nov 26.

PMID:
15572765
18.
19.

Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor.

King NM, Prabu-Jeyabalan M, Nalivaika EA, Wigerinck P, de Béthune MP, Schiffer CA.

J Virol. 2004 Nov;78(21):12012-21.

20.

The CCP4 suite: programs for protein crystallography.

Collaborative Computational Project, Number 4.

Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3.

PMID:
15299374

Supplemental Content

Support Center